Cost

CMS released a proposed physician payment rule for 2026 that ties cost policy to broader payment reform, including accountable care incentives and updates to physician reimbursement. The agency says the proposal would help modernize payment while avoiding an estimated $2.38 billion in improper advanced alternative payment model incentive payments over 10 years. For cost watchers, the proposal is notable because it frames physician payment changes as both a budget issue and a lever for moving Medicare away from volume-driven care.

CMS proposed OPPS and ASC payment changes aimed at affordability for Medicare beneficiaries, with a focus on drug payment policy, site-of-care incentives, and lower out-of-pocket costs. The agency highlights 340B drug payment changes and projected savings for Medicare and taxpayers, alongside reforms intended to reduce incentives that can make hospital outpatient care more expensive. The proposal is significant on cost because it combines beneficiary affordability with federal savings and provider payment redesign.

CMS issued guidance signaling tighter oversight of budget neutrality for Medicaid section 1115 demonstrations. The move centers on constraining how demonstration spending is measured and justified, with direct consequences for both federal and state Medicaid costs. This is a meaningful cost development because it could limit financing flexibility that states have used to support higher spending under waiver authority.

CMS finalized changes to the No Surprises Act independent dispute resolution process that lower administrative fees and revise batching and transparency rules. While the rule mainly addresses insurer-provider payment disputes, its cost relevance lies in reducing administrative friction and fees tied to resolving out-of-network payment disagreements. The changes could affect system costs indirectly by altering how often disputes are filed and what they cost to pursue.

CMS proposed Medicaid managed-care financing and payment changes aimed at state directed payments, provider taxes, and spending growth. The agency says the proposal would curb financing practices it views as inflating federal Medicaid costs while tying payments more closely to quality. Cost implications are potentially large because the rule targets mechanisms many states use to raise provider payments and draw down federal funds.

CMS finalized its 2027 Payment Notice with lower Exchange user fees and other policy changes affecting individual-market affordability and oversight. The agency presents the rule as a cost-lowering measure that also addresses fraud and gives states more flexibility, with implications for premiums, administrative expenses, and coverage dynamics. For a cost-focused audience, the key issue is how marketplace fee and affordability policy can shape what enrollees and taxpayers pay.

MedPAC’s March 2026 report to Congress reviews Medicare payment adequacy, beneficiary cost burdens, spending trends, and reform options across major payment systems. It provides a cross-cutting baseline for understanding where Medicare costs are rising, how payment rates compare with provider costs, and what policy changes lawmakers could consider. The report is especially useful for comparing cost pressures across hospital, physician, post-acute, and other sectors rather than focusing on a single CMS rule.

MACPAC’s March 2026 report includes analysis of Medicaid payment policy for the home- and community-based services workforce, linking payment rates to access and long-term spending pressures. Although narrower than a full program financing review, it addresses how states can use payment policy to stabilize care delivery and affordability in long-term services and supports. The report is relevant to cost because workforce payment decisions can influence both near-term Medicaid spending and the availability of less institutional care settings.